JOOS MOERLAND: Open Payments
NPI 1710638432 · KNOX, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 63 payments from 16 companies in 2025. Trend: 2023 $990 · 2024 $1,170 · 2025 $1,386
Food & beverage: $1,386
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $265 |
| ABBVIE INC. | 12 | $191 |
| Lilly USA, LLC | 7 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $136 |
| Novo Nordisk Inc | 5 | $99 |
| Vanda Pharmaceuticals Inc. | 3 | $98 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Exact Sciences Corporation | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
Products named: BREZTRI, MOUNJARO, CAPLYTA, VRAYLAR, FANAPT, Auvelity, Kerendia, Ozempic.
Industry payments across IN — which companies pay providers there.
